MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International

MonoSol Rx, LLC filed an amended patent infringement and false marking lawsuit today against BioDelivery Sciences International, Inc. BDSI, MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc. in the United States District Court for the District of New Jersey. MonoSol Rx's complaint asserts that BDSI, MEDA, and Aveva's manufacture, marketing, and sale of the Onsolis™ film products infringe MonoSol Rx's United States Patent No. 7,824,588 related to methods of making drug-containing films. As one of the leaders in the development and commercialization of film pharmaceutical and over-the-counter drug products, MonoSol Rx has an extensive technology patent portfolio.